Fisher V.L., Tahrani A.A. Cardiac autonomic neuropathy in patients with diabetes mellitus: current perspectives. Diabetes Metab Syndr Obes. 2017 Oct 6;10:419-434. doi: 10.2147/ DMSO.S129797. eCollection 2017..
DOI: 10.2147/ DMSO.S129797. eCollection 2017
Domingueti C.P., Dusse L.M., Carvalho M.G., de Sousa L.P., Gomes K.B., Fernandes A.P. Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. J Diabetes Complications. 2016;30(4):738–745.
Balcıoğlu A.S., Müderrisoğlu H. Diabetes and cardiac autonomic neuropathy: clinical manifestations, cardiovascular consequences, diagnosis and treatment. World J Diabetes. 2015;6(1):80–91.
Spallone V., Ziegler D., Freeman R., et al. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011;27(7):639–653.
Dimitropoulos G., Tahrani A.A., Stevens M.J. Cardiac autonomic neuropathy in patients with diabetes mellitus. World J Diabetes. 2014;5(1):17–39.
Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058–1070.
Pop-Busui R., Low P.A., Waberski B.H., et al. Effects of prior intensive insulin therapy on cardiac autonomic nervous system function in type 1 diabetes mellitus: the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications study (DCCT/EDIC). Circulation. 2009;119(22):2886–2893.
Pop-Busui R., Braffett B.H., Zinman B., et al. Cardiovascular autonomic neuropathy and cardiovascular outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes Care. 2017;40(1):94–100.
Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010;33(2):434–441.
Dimova R., Tankova T., Guergueltcheva V., et al. Risk factors for autonomic and somatic nerve dysfunction in different stages of glucose tolerance. J Diabetes Complications. 2017;31(3):537–543.
Low P.A., Benrud-Larson L.M., Sletten D.M., et al. Autonomic symptoms and diabetic neuropathy: a population-based study. Diabetes Care. 2004;27(12):2942–2947.
Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev. 1994;10(4):339–383.
Boulton A.J., Vinik A.I., Arezzo J.C., et al. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956–962.
Witte D.R., Tesfaye S., Chaturvedi N., et al. Risk factors for cardiac autonomic neuropathy in type 1 diabetes mellitus. Diabetologia. 2005;48(1):164–171.
Chung J.O., Park S.Y., Cho D.H., Chung D.J., Chung M.Y. Anemia, bilirubin, and cardiovascular autonomic neuropathy in patients with type 2 diabetes. Medicine (Baltimore). 2017;96(15):e6586.
Valensi P., Pariès J., Attali J.R. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications – the French multicenter study. Metabolism. 2003;52(7):815–820.
Maser R.E., Lenhard M.J. Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab. 2005;90(10):5896–5903.
Kempler P., Tesfaye S., Chaturvedi N., et al. Autonomic neuropathy is associated with increased cardiovascular risk factors: the EURODIAB IDDM complications study. Diabet Med. 2002;19(11):900–909.
Ko S.H., Park S.A., Cho J.H., et al. Progression of cardiovascular autonomic dysfunction in patients with type 2 diabetes: a 7-year followup study. Diabetes Care. 2008;31(9):1832–1836.
Huang C.C., Lee J.J., Lin T.K., et al. Diabetic retinopathy is strongly predictive of cardiovascular autonomic neuropathy in type 2 diabetes. J Diabetes Res. 2016;2016:6090749.
Tannus L.R., Drummond K.R., Clemente E.L., da Matta M.F., Gomes M.B. Predictors of cardiovascular autonomic neuropathy in patients with type 1 diabetes. Front Endocrinol (Lausanne). 2014;5:191.
Charles M., Fleischer J., Witte D.R., et al. Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study. Diabetologia. 2013;56(1):101– 108.
Vinik A.I., Freeman R., Erbas T. Diabetic autonomic neuropathy. Semin Neurol. 2003;23(4):365–372.
Pop-Busui R. What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes. J Cardiovasc Transl Res. 2012;5(4):463–478.
Hillis G., Woodward M., Rodgers A., et al. Resting heart rate and the risk of death and cardiovascular complications in patients with type 2 diabetes mellitus. Diabetologia. 2012;55(5):1283–1290.
Vinik A.I., Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387–397.
Kuehl M., Stevens M.J. Cardiovascular autonomic neuropathies as complications of diabetes mellitus. Nat Rev Endocrinol. 2012;8(7):405– 416.
Ninkovic V.M., Ninkovic S.M., Miloradovic V., et al. Prevalence and risk factors for prolonged QT interval and QT dispersion in patients with type 2 diabetes. Acta Diabetol. 2016;53(5):737– 744.
Edwards J.L., Vincent A.M., Cheng H.T., Feldman E.L. Diabetic neuropathy: mechanisms to management. Pharmacol Ther. 2008;120(1):1–34.
Gibbons C., Centi J., Vernino S., Freeman R. Autoimmune autonomic ganglionopathy with reversible cognitive impairment. Arch Neurol. 2012;69(4):461–466.
Politi C., Ciccacci C., D’Amato C., Novelli G., Borgiani P., Spallone V. Recent advances in exploring the genetic susceptibility to diabetic neuropathy. Diabetes Res Clin Pract. 2016;120:198–208.
Tahrani A.A., Ali A., Raymond N.T., et al. Obstructive sleep apnea and diabetic neuropathy: a novel association in patients with type 2 diabetes. Am J Respir Crit Care Med. 2012;186(5):434–441.
Vinik A.I., Erbas T., Casellini C.M. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. J Diabetes Investig. 2013;4(1):4–18.
Ziegler D., Buchholz S., Sohr C., Nourooz-Zadeh J., Roden M. Oxidative stress predicts progression of peripheral and cardiac autonomic nerve dysfunction over 6 years in diabetic
patients. Acta Diabetol. 2015;52(1):65–72.
Jaiswal M., Fingerlin T.E., Urbina E.M., et al. Impact of glycemic control on heart rate variability in youth with type 1 diabetes: the SEARCH CVD study. Diabetes Technol Ther. 2013;15(12):977–983.
Shah M.S., Brownlee M. Molecular and cellular mechanisms of cardiovascular disorders in diabetes. Circ Res. 2016;118(11):1808–1829.
Котова О.В. Диабетическая автономная полиневропатия. Фарматека. 2012;6:40-44.
Thornalley P., Babaei-Jadidi R., Al Ali H. et al. High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease. Diabetologia. 2007;50(10):2164–2170.
Cameron N., Gibson T., Nangle M. Inhibitors of advanced glycation end product formation and neurovascular dysfunction in experimental diabetes. Ann N Y Acad Sci. 2005;1043:784–92.
Строков И.А., Ахмеджанова Л.Т., Солоха О.А. Витамины группы В в лечении неврологических заболеваний. РМЖ. 2009;11:776.
Куцемелов И.Б., Беркут О.А., Кушнарева В.В., Постникова А.С. Алгоритмы и клинические рекомендации по использованию препарата Нейромультивит в неврологической практике. РМЖ. Медицинское обозрение. 2014;31:2186.
Shipton M.J., Thachil J. Vitamin B12 deficiency – A 21st century perspective. Clin Med (Lond). 2015 Apr;15(2):145-50. doi: 10.7861/clinmedicine.15-2-145..
DOI: 10.7861/clinmedicine.15-2-145
Wang H., Li L., Qin L.L., Song Y., Vidal-Alaball J., Liu T.H. Oral vitamin B12 versus intramuscular vitamin B12 for vitamin B12 deficiency. Cochrane Database Syst Rev. 2018 Mar 15;3.
Howorka K., Pumprla J., Haber P., Koller-Strametz J., Mondrzyk J., Schabmann A. Effects of physical training on heart rate variability in diabetic patients with various degrees of cardiovascular autonomic neuropathy. Cardiovasc Res. 1997;34(1):206–214.
Котова О.В. Диабетическая нейропатия. Применение нейротропных витаминов. Поликлиника. 2015;1(2):36-39.